glycyl-arginyl-glycyl-aspartyl-serine has been researched along with EHS Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forsberg, E; Johansson, S; Lindblom, A; Paulsson, M | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and EHS Tumor
| Article | Year |
|---|---|
Laminin isoforms promote attachment of hepatocytes via different integrins.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Adhesion; Cells, Cultured; Collagen; Heart; Immunoglobulin G; Integrins; Kinetics; Laminin; Liver; Mice; Oligopeptides; Rats; Sarcoma, Experimental; Tumor Cells, Cultured | 1994 |